Mimedx (MDXG) Gross Profit (QoQ) (2011 - 2026)

Mimedx (MDXG) Gross Profit (QoQ) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Mimedx 635.35 Mn 475.58 Mn 41.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -57.97%
Dec 31, 2025 4.25%
Sep 30, 2025 18.87%
Jun 30, 2025 11.55%
Mar 31, 2025 -5.73%
Dec 31, 2024 10.57%
Sep 30, 2024 -5.00%
Jun 30, 2024 0.88%
Mar 31, 2024 -1.74%
Dec 31, 2023 9.07%
Sep 30, 2023 -1.11%
Jun 30, 2023 14.20%
Mar 31, 2023 -1.25%
Dec 31, 2022 8.12%
Sep 30, 2022 0.80%
Jun 30, 2022 12.46%
Mar 31, 2022 11.99%
Dec 31, 2021 -17.43%
Sep 30, 2021 -4.44%
Jun 30, 2021 10.09%